Main> Doxycycline> Imitrex nasal spray dosage

Imitrex nasal spray dosage

Sumatriptan nasal spray is used to treat the symptoms of mraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and lht). It helps to relieve headache, pain, and other mraine symptoms (including nausea, vomiting, sensitivity to lht/sound). To relieve your mraine as soon as possible, use this medicine as soon as the headache pain begins.

Imitrex nasal spray dosage

Imitrex nasal spray dosage

Doses of Imitrex (sumatriptan) work differently in different people. The dose should therefore be made on an individual basis, wehing the possible benefit of a hher dose with possible side effect risks.

  • DISCOUNT BUY FLOMAX
  • ABILIFY AND SEIZURES
  • BUY METFORMIN IN UK
  • Cialis comparison viagra
  • How long does it take viagra to start working

  • Serotonin syndrome with SSRIs (eg, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline) or SNRIs (eg, duloxetine, venlafaxine).


    Imitrex nasal spray dosage

    Imitrex nasal spray dosage

    Imitrex nasal spray dosage

    Use only if a clear diagnosis of mraine headache has been established. Unless explained differently, the information for "Imran nasal spray" in this leaflet applies to both Imran S nasal spray 10 mg and Imran nasal spray 20 mg (refer to the "Product description" section near the end of the leaflet for a description of these two products).

    Imitrex nasal spray dosage

    Atypical Sensations: Tingling, numbness, pressure sensation, cold sensation, feeling of thtness Cardiovascular: Flushing, hypertension, palpations, tachycardia, arrhythmia, edema Chest thtness/discomfort, chest pressure/heaviness Disturbance of hearing, ear infections Eye irritation and visual disturbances Gastrointestinal: Abdominal discomfort, diarrhea, dysphagia, GERD, dry mouth, thirst Musculoskeletal: Neck pain/stiffness, backache, weakness, joint symptoms, arthritis, myalgia, muscle cramps Neurological: Drowsiness/sedation, anxiety, sleep disturbances, tremors, syncope, chills, depression, agitation, confusion Respiratory: Dyspnea, lower respiratory infection Skin: Rash/skin eruption, pruritus, erythema Urogenital: Dysuria, dysmenorrhea Blood: Hemolytic anemia, pancytopenia, thrombocytopenia Cardiovascular: Atrial fibrillation, cardiomyopathy, colonic ischemia, Prinzmetal variant angina, pulmonary embolism, shock, thrombopebitis Ear, nose, throat: Deafness Eye: Ischemic optic neuropathy, retinal artery occlusion, retinal vein thrombosis, loss of vision Gastrointestinal: Ischemic colitis, dry mouth Hepatic: Elevated LFTs Neurological: CNS vasculitis, cerebrovascular accident, dysphasia, serotonin syndrome, subarachnoid hemorrhage Psychiatric: Panic disorder Respiratory: bronchospasm in patients with or without a history of asthma Skin: exacerbation of sunburn, hypersensitivity reactions (erythema, pruritus, rash), photosensitivity Urogenital: acute renal failure Nonspecific: Angioneurotic edema, cyanosis, death, temporal arteritis Current/history of: ischemic cardiac, cerebrovascular, or peripheral vascular syndromes (angina, MI, stroke, TIA, ischemic bowel disease) Uncontrolled hypertension Coadministration of MAO-A inhibitors or use within 2 weeks after discontinuing MAO-A inhibitors Use within 24 hr of any ergotamine-containing or ergot-type medication (eg, dihydroergotamine or methysergide) Use within 24 hr of other 5-HT1 agonists Hypersensitivity Severe hepatic impairment Not indicated for basilar or hemiplegic mraine Clear diagnosis of mraine headache has been established Overuse of acute mraine drugs (eg, ergotamine, triptans, opioids, or combination of these drugs for ≥10 days/month) may lead to exacerbation of headache (medication overuse headache) Serious cardiac and cerebrovascular events, including cerebral hemorrhage, subarachnoid hemorrhage, stroke, acute MI, arrhythmias, and death reported within a few hours after administration Chest discomfort and jaw or neck thtness reported infrequently following intranasal administration (relatively common following SC injection) Not for use with unrecognized CAD as predicted by risk factors (eg, hypertension, hypercholesterolemia, smoking, obesity, diabetes, strong family history of CAD, female with surgical or physiological menopause, male aged 40 yr) Serotonin syndrome may occur, particularly when coadministered with SSRIs (eg, fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, escitalopram) or SNRIs (eg, venlafaxine, duloxetine) Increased blood pressure, including hypertensive crisis reported (rare) Local irritation of nose and throat reported Pregnancy Category: C Reproductive toxicity studies for sumatriptan by intranasal route have not been conducted; embryolethality and blood vessel abnormalities observed with PO or IV doses in pregnant rabbits during organogenesis Lactation: Excreted in human breast milk in very low levels (NLM Toxnet); minimize infant to potential exposure by avoiding breastfeeding for 8-12 hr after administration The above information is provided for general informational and educational purposes only. PRESCRIPTION DRUG CALLED LEXAPRO


    Imitrex nasal spray dosage:

    Rating: 92 / 100

    Overall: 98 Rates
  • binancebinance exchangebinance exchange website